世界の呼吸障害・治療市場規模・現状・予測2021-2027

【英語タイトル】Global Breathing Disorders & Treatment Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR1001)・商品コード:QY21APR1001
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:153
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、呼吸障害・治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(喘息、COPD、アレルギー性鼻炎、肺高血圧症、嚢胞性線維症、特発性肺線維症)、用途別市場規模(病院、クリニック、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・呼吸障害・治療の市場動向
・企業の競争状況、市場シェア
・呼吸障害・治療の種類別市場規模(喘息、COPD、アレルギー性鼻炎、肺高血圧症、嚢胞性線維症、特発性肺線維症)
・呼吸障害・治療の用途別市場規模(病院、クリニック、その他)
・呼吸障害・治療の北米市場規模2016-2027(アメリカ、カナダ)
・呼吸障害・治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・呼吸障害・治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・呼吸障害・治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・呼吸障害・治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(AstraZeneca、Boehringer、GSK、Merck、Roche、Novartis、Abbott、Actavis、Afferent Pharmaceuticals、Abbott、Almirall、Amgen、AptarGroup、Astellas、Aurobindo、Axis-Shield、Baxter、Bayer、Biogen、Biotest、Bristol-Myers Squibb、Chiesi Farmaceutici、Cipla、Cytos、Dainippon Sumitomo、Dr. Reddy's Laboratories)
・結論
【レポートの概要】

The respiratory therapy area consists of indications that affect the respiratory system in different ways, such as the scarring of lung tissue, and excessive production of mucus in the airways, thereby decreasing lung function. Some of the key indications in this therapy area include asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and idiopathic pulmonary fibrosis (IPF). The causes of respiratory disorders vary significantly across each indication, and include factors such as environment, occupation, genetic predisposition and aging.

Market Analysis and Insights: Global Breathing Disorders & Treatment Market
The global Breathing Disorders & Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breathing Disorders & Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breathing Disorders & Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breathing Disorders & Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breathing Disorders & Treatment market.

Global Breathing Disorders & Treatment Scope and Market Size
Breathing Disorders & Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breathing Disorders & Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Asthma
COPD
Allergic rhinitis
Pulmonary hypertension
Cystic fibrosis
Idiopathic pulmonary fibrosis

Segment by Application
Hospital
Clinics
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Boehringer
GSK
Merck
Roche
Novartis
Abbott
Actavis
Afferent Pharmaceuticals
Merck
Roche
Amgen
AptarGroup
Astellas
Aurobindo
Axis-Shield
Baxter
Bayer
Biogen
Biotest
Bristol-Myers Squibb
Chiesi Farmaceutici
Cipla
Cytos

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breathing Disorders & Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Asthma
1.2.3 COPD
1.2.4 Allergic rhinitis
1.2.5 Pulmonary hypertension
1.2.6 Cystic fibrosis
1.2.7 Idiopathic pulmonary fibrosis
1.3 Market by Application
1.3.1 Global Breathing Disorders & Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Breathing Disorders & Treatment Market Perspective (2016-2027)
2.2 Breathing Disorders & Treatment Growth Trends by Regions
2.2.1 Breathing Disorders & Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Breathing Disorders & Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Breathing Disorders & Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Breathing Disorders & Treatment Industry Dynamic
2.3.1 Breathing Disorders & Treatment Market Trends
2.3.2 Breathing Disorders & Treatment Market Drivers
2.3.3 Breathing Disorders & Treatment Market Challenges
2.3.4 Breathing Disorders & Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Breathing Disorders & Treatment Players by Revenue
3.1.1 Global Top Breathing Disorders & Treatment Players by Revenue (2016-2021)
3.1.2 Global Breathing Disorders & Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Breathing Disorders & Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Breathing Disorders & Treatment Revenue
3.4 Global Breathing Disorders & Treatment Market Concentration Ratio
3.4.1 Global Breathing Disorders & Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breathing Disorders & Treatment Revenue in 2020
3.5 Breathing Disorders & Treatment Key Players Head office and Area Served
3.6 Key Players Breathing Disorders & Treatment Product Solution and Service
3.7 Date of Enter into Breathing Disorders & Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Breathing Disorders & Treatment Breakdown Data by Type
4.1 Global Breathing Disorders & Treatment Historic Market Size by Type (2016-2021)
4.2 Global Breathing Disorders & Treatment Forecasted Market Size by Type (2022-2027)

5 Breathing Disorders & Treatment Breakdown Data by Application
5.1 Global Breathing Disorders & Treatment Historic Market Size by Application (2016-2021)
5.2 Global Breathing Disorders & Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Breathing Disorders & Treatment Market Size (2016-2027)
6.2 North America Breathing Disorders & Treatment Market Size by Type
6.2.1 North America Breathing Disorders & Treatment Market Size by Type (2016-2021)
6.2.2 North America Breathing Disorders & Treatment Market Size by Type (2022-2027)
6.2.3 North America Breathing Disorders & Treatment Market Size by Type (2016-2027)
6.3 North America Breathing Disorders & Treatment Market Size by Application
6.3.1 North America Breathing Disorders & Treatment Market Size by Application (2016-2021)
6.3.2 North America Breathing Disorders & Treatment Market Size by Application (2022-2027)
6.3.3 North America Breathing Disorders & Treatment Market Size by Application (2016-2027)
6.4 North America Breathing Disorders & Treatment Market Size by Country
6.4.1 North America Breathing Disorders & Treatment Market Size by Country (2016-2021)
6.4.2 North America Breathing Disorders & Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Breathing Disorders & Treatment Market Size (2016-2027)
7.2 Europe Breathing Disorders & Treatment Market Size by Type
7.2.1 Europe Breathing Disorders & Treatment Market Size by Type (2016-2021)
7.2.2 Europe Breathing Disorders & Treatment Market Size by Type (2022-2027)
7.2.3 Europe Breathing Disorders & Treatment Market Size by Type (2016-2027)
7.3 Europe Breathing Disorders & Treatment Market Size by Application
7.3.1 Europe Breathing Disorders & Treatment Market Size by Application (2016-2021)
7.3.2 Europe Breathing Disorders & Treatment Market Size by Application (2022-2027)
7.3.3 Europe Breathing Disorders & Treatment Market Size by Application (2016-2027)
7.4 Europe Breathing Disorders & Treatment Market Size by Country
7.4.1 Europe Breathing Disorders & Treatment Market Size by Country (2016-2021)
7.4.2 Europe Breathing Disorders & Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Breathing Disorders & Treatment Market Size (2016-2027)
8.2 Asia-Pacific Breathing Disorders & Treatment Market Size by Type
8.2.1 Asia-Pacific Breathing Disorders & Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Breathing Disorders & Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Breathing Disorders & Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Breathing Disorders & Treatment Market Size by Application
8.3.1 Asia-Pacific Breathing Disorders & Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Breathing Disorders & Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Breathing Disorders & Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Breathing Disorders & Treatment Market Size by Region
8.4.1 Asia-Pacific Breathing Disorders & Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Breathing Disorders & Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Breathing Disorders & Treatment Market Size (2016-2027)
9.2 Latin America Breathing Disorders & Treatment Market Size by Type
9.2.1 Latin America Breathing Disorders & Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Breathing Disorders & Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Breathing Disorders & Treatment Market Size by Type (2016-2027)
9.3 Latin America Breathing Disorders & Treatment Market Size by Application
9.3.1 Latin America Breathing Disorders & Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Breathing Disorders & Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Breathing Disorders & Treatment Market Size by Application (2016-2027)
9.4 Latin America Breathing Disorders & Treatment Market Size by Country
9.4.1 Latin America Breathing Disorders & Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Breathing Disorders & Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Breathing Disorders & Treatment Market Size (2016-2027)
10.2 Middle East & Africa Breathing Disorders & Treatment Market Size by Type
10.2.1 Middle East & Africa Breathing Disorders & Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Breathing Disorders & Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Breathing Disorders & Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Breathing Disorders & Treatment Market Size by Application
10.3.1 Middle East & Africa Breathing Disorders & Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Breathing Disorders & Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Breathing Disorders & Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Breathing Disorders & Treatment Market Size by Country
10.4.1 Middle East & Africa Breathing Disorders & Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Breathing Disorders & Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Breathing Disorders & Treatment Introduction
11.1.4 AstraZeneca Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Boehringer
11.2.1 Boehringer Company Details
11.2.2 Boehringer Business Overview
11.2.3 Boehringer Breathing Disorders & Treatment Introduction
11.2.4 Boehringer Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.2.5 Boehringer Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Breathing Disorders & Treatment Introduction
11.3.4 GSK Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Breathing Disorders & Treatment Introduction
11.4.4 Merck Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Breathing Disorders & Treatment Introduction
11.5.4 Roche Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.5.5 Roche Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Breathing Disorders & Treatment Introduction
11.6.4 Novartis Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Breathing Disorders & Treatment Introduction
11.7.4 Abbott Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 Actavis
11.8.1 Actavis Company Details
11.8.2 Actavis Business Overview
11.8.3 Actavis Breathing Disorders & Treatment Introduction
11.8.4 Actavis Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.8.5 Actavis Recent Development
11.9 Afferent Pharmaceuticals
11.9.1 Afferent Pharmaceuticals Company Details
11.9.2 Afferent Pharmaceuticals Business Overview
11.9.3 Afferent Pharmaceuticals Breathing Disorders & Treatment Introduction
11.9.4 Afferent Pharmaceuticals Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.9.5 Afferent Pharmaceuticals Recent Development
11.10 Abbott
11.10.1 Abbott Company Details
11.10.2 Abbott Business Overview
11.10.3 Abbott Breathing Disorders & Treatment Introduction
11.10.4 Abbott Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.10.5 Abbott Recent Development
11.11 Almirall
11.11.1 Almirall Company Details
11.11.2 Almirall Business Overview
11.11.3 Almirall Breathing Disorders & Treatment Introduction
11.11.4 Almirall Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.11.5 Almirall Recent Development
11.12 Amgen
11.12.1 Amgen Company Details
11.12.2 Amgen Business Overview
11.12.3 Amgen Breathing Disorders & Treatment Introduction
11.12.4 Amgen Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.12.5 Amgen Recent Development
11.13 AptarGroup
11.13.1 AptarGroup Company Details
11.13.2 AptarGroup Business Overview
11.13.3 AptarGroup Breathing Disorders & Treatment Introduction
11.13.4 AptarGroup Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.13.5 AptarGroup Recent Development
11.14 Astellas
11.14.1 Astellas Company Details
11.14.2 Astellas Business Overview
11.14.3 Astellas Breathing Disorders & Treatment Introduction
11.14.4 Astellas Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.14.5 Astellas Recent Development
11.15 Aurobindo
11.15.1 Aurobindo Company Details
11.15.2 Aurobindo Business Overview
11.15.3 Aurobindo Breathing Disorders & Treatment Introduction
11.15.4 Aurobindo Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.15.5 Aurobindo Recent Development
11.16 Axis-Shield
11.16.1 Axis-Shield Company Details
11.16.2 Axis-Shield Business Overview
11.16.3 Axis-Shield Breathing Disorders & Treatment Introduction
11.16.4 Axis-Shield Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.16.5 Axis-Shield Recent Development
11.17 Baxter
11.17.1 Baxter Company Details
11.17.2 Baxter Business Overview
11.17.3 Baxter Breathing Disorders & Treatment Introduction
11.17.4 Baxter Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.17.5 Baxter Recent Development
11.18 Bayer
11.18.1 Bayer Company Details
11.18.2 Bayer Business Overview
11.18.3 Bayer Breathing Disorders & Treatment Introduction
11.18.4 Bayer Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.18.5 Bayer Recent Development
11.18 Biogen
11.25.1 Biogen Company Details
11.25.2 Biogen Business Overview
11.25.3 Biogen Breathing Disorders & Treatment Introduction
11.25.4 Biogen Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.25.5 Biogen Recent Development
11.20 Biotest
11.20.1 Biotest Company Details
11.20.2 Biotest Business Overview
11.20.3 Biotest Breathing Disorders & Treatment Introduction
11.20.4 Biotest Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.20.5 Biotest Recent Development
11.21 Bristol-Myers Squibb
11.21.1 Bristol-Myers Squibb Company Details
11.21.2 Bristol-Myers Squibb Business Overview
11.21.3 Bristol-Myers Squibb Breathing Disorders & Treatment Introduction
11.21.4 Bristol-Myers Squibb Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.21.5 Bristol-Myers Squibb Recent Development
11.22 Chiesi Farmaceutici
11.22.1 Chiesi Farmaceutici Company Details
11.22.2 Chiesi Farmaceutici Business Overview
11.22.3 Chiesi Farmaceutici Breathing Disorders & Treatment Introduction
11.22.4 Chiesi Farmaceutici Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.22.5 Chiesi Farmaceutici Recent Development
11.23 Cipla
11.23.1 Cipla Company Details
11.23.2 Cipla Business Overview
11.23.3 Cipla Breathing Disorders & Treatment Introduction
11.23.4 Cipla Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.23.5 Cipla Recent Development
11.24 Cytos
11.24.1 Cytos Company Details
11.24.2 Cytos Business Overview
11.24.3 Cytos Breathing Disorders & Treatment Introduction
11.24.4 Cytos Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.24.5 Cytos Recent Development
11.25 Dainippon Sumitomo
11.25.1 Dainippon Sumitomo Company Details
11.25.2 Dainippon Sumitomo Business Overview
11.25.3 Dainippon Sumitomo Breathing Disorders & Treatment Introduction
11.25.4 Dainippon Sumitomo Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.25.5 Dainippon Sumitomo Recent Development
11.26 Dr. Reddy’s Laboratories
11.26.1 Dr. Reddy’s Laboratories Company Details
11.26.2 Dr. Reddy’s Laboratories Business Overview
11.26.3 Dr. Reddy’s Laboratories Breathing Disorders & Treatment Introduction
11.26.4 Dr. Reddy’s Laboratories Revenue in Breathing Disorders & Treatment Business (2016-2021)
11.26.5 Dr. Reddy’s Laboratories Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Breathing Disorders & Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Asthma
Table 3. Key Players of COPD
Table 4. Key Players of Allergic rhinitis
Table 5. Key Players of Pulmonary hypertension
Table 6. Key Players of Cystic fibrosis
Table 7. Key Players of Idiopathic pulmonary fibrosis
Table 8. Global Breathing Disorders & Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Breathing Disorders & Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Breathing Disorders & Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Breathing Disorders & Treatment Market Share by Regions (2016-2021)
Table 12. Global Breathing Disorders & Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Breathing Disorders & Treatment Market Share by Regions (2022-2027)
Table 14. Breathing Disorders & Treatment Market Trends
Table 15. Breathing Disorders & Treatment Market Drivers
Table 16. Breathing Disorders & Treatment Market Challenges
Table 17. Breathing Disorders & Treatment Market Restraints
Table 18. Global Breathing Disorders & Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Breathing Disorders & Treatment Market Share by Players (2016-2021)
Table 20. Global Top Breathing Disorders & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breathing Disorders & Treatment as of 2020)
Table 21. Ranking of Global Top Breathing Disorders & Treatment Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Breathing Disorders & Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Breathing Disorders & Treatment Product Solution and Service
Table 25. Date of Enter into Breathing Disorders & Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Breathing Disorders & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Breathing Disorders & Treatment Revenue Market Share by Type (2016-2021)
Table 29. Global Breathing Disorders & Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Breathing Disorders & Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Breathing Disorders & Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Breathing Disorders & Treatment Revenue Market Share by Application (2016-2021)
Table 33. Global Breathing Disorders & Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Breathing Disorders & Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Breathing Disorders & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Breathing Disorders & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Breathing Disorders & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Breathing Disorders & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Breathing Disorders & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Breathing Disorders & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Breathing Disorders & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Breathing Disorders & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Breathing Disorders & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Breathing Disorders & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Breathing Disorders & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Breathing Disorders & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Breathing Disorders & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Breathing Disorders & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Breathing Disorders & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Breathing Disorders & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Breathing Disorders & Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Breathing Disorders & Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Breathing Disorders & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Breathing Disorders & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Breathing Disorders & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Breathing Disorders & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Breathing Disorders & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Breathing Disorders & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Breathing Disorders & Treatment Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Breathing Disorders & Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Breathing Disorders & Treatment Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Breathing Disorders & Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Breathing Disorders & Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Breathing Disorders & Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 65. AstraZeneca Company Details
Table 66. AstraZeneca Business Overview
Table 67. AstraZeneca Breathing Disorders & Treatment Product
Table 68. AstraZeneca Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 69. AstraZeneca Recent Development
Table 70. Boehringer Company Details
Table 71. Boehringer Business Overview
Table 72. Boehringer Breathing Disorders & Treatment Product
Table 73. Boehringer Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 74. Boehringer Recent Development
Table 75. GSK Company Details
Table 76. GSK Business Overview
Table 77. GSK Breathing Disorders & Treatment Product
Table 78. GSK Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 79. GSK Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Breathing Disorders & Treatment Product
Table 83. Merck Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 84. Merck Recent Development
Table 85. Roche Company Details
Table 86. Roche Business Overview
Table 87. Roche Breathing Disorders & Treatment Product
Table 88. Roche Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 89. Roche Recent Development
Table 90. Novartis Company Details
Table 91. Novartis Business Overview
Table 92. Novartis Breathing Disorders & Treatment Product
Table 93. Novartis Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 94. Novartis Recent Development
Table 95. Abbott Company Details
Table 96. Abbott Business Overview
Table 97. Abbott Breathing Disorders & Treatment Product
Table 98. Abbott Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 99. Abbott Recent Development
Table 100. Actavis Company Details
Table 101. Actavis Business Overview
Table 102. Actavis Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 103. Actavis Recent Development
Table 104. Afferent Pharmaceuticals Company Details
Table 105. Afferent Pharmaceuticals Business Overview
Table 106. Afferent Pharmaceuticals Breathing Disorders & Treatment Product
Table 107. Afferent Pharmaceuticals Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 108. Afferent Pharmaceuticals Recent Development
Table 109. Abbott Company Details
Table 110. Abbott Business Overview
Table 111. Abbott Breathing Disorders & Treatment Product
Table 112. Abbott Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 113. Abbott Recent Development
Table 114. Almirall Company Details
Table 115. Almirall Business Overview
Table 116. Almirall Breathing Disorders & Treatment Product
Table 117. Almirall Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 118. Almirall Recent Development
Table 119. Amgen Company Details
Table 120. Amgen Business Overview
Table 121. Amgen Breathing Disorders & Treatment Product
Table 122. Amgen Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 123. Amgen Recent Development
Table 124. AptarGroup Company Details
Table 125. AptarGroup Business Overview
Table 126. AptarGroup Breathing Disorders & Treatment Product
Table 127. AptarGroup Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 128. AptarGroup Recent Development
Table 129. Astellas Company Details
Table 130. Astellas Business Overview
Table 131. Astellas Breathing Disorders & Treatment Product
Table 132. Astellas Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 133. Astellas Recent Development
Table 134. Aurobindo Company Details
Table 135. Aurobindo Business Overview
Table 136. Aurobindo Breathing Disorders & Treatment Product
Table 137. Aurobindo Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 138. Aurobindo Recent Development
Table 139. Axis-Shield Company Details
Table 140. Axis-Shield Business Overview
Table 141. Axis-Shield Breathing Disorders & Treatment Product
Table 142. Axis-Shield Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 143. Axis-Shield Recent Development
Table 144. Baxter Company Details
Table 145. Baxter Business Overview
Table 146. Baxter Breathing Disorders & Treatment Product
Table 147. Baxter Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 148. Baxter Recent Development
Table 149. Bayer Company Details
Table 150. Bayer Business Overview
Table 151. Bayer Breathing Disorders & Treatment Product
Table 152. Bayer Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 153. Bayer Recent Development
Table 154. Biogen Company Details
Table 155. Biogen Business Overview
Table 156. Biogen Breathing Disorders & Treatment Product
Table 157. Biogen Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 158. Biogen Recent Development
Table 159. Biotest Company Details
Table 160. Biotest Business Overview
Table 161. Biotest Breathing Disorders & Treatment Product
Table 162. Biotest Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 163. Biotest Recent Development
Table 164. Bristol-Myers Squibb Company Details
Table 165. Bristol-Myers Squibb Business Overview
Table 166. Bristol-Myers Squibb Breathing Disorders & Treatment Product
Table 167. Bristol-Myers Squibb Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 168. Bristol-Myers Squibb Recent Development
Table 169. Chiesi Farmaceutici Company Details
Table 170. Chiesi Farmaceutici Business Overview
Table 171. Chiesi Farmaceutici Breathing Disorders & Treatment Product
Table 172. Chiesi Farmaceutici Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 173. Chiesi Farmaceutici Recent Development
Table 174. Cipla Company Details
Table 175. Cipla Business Overview
Table 176. Cipla Breathing Disorders & Treatment Product
Table 177. Cipla Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 178. Cipla Recent Development
Table 179. Cytos Company Details
Table 180. Cytos Business Overview
Table 181. Cytos Breathing Disorders & TreatmentProduct
Table 182. Cytos Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 183. Cytos Recent Development
Table 184. Dainippon Sumitomo Company Details
Table 185. Dainippon Sumitomo Business Overview
Table 186. Dainippon Sumitomo Breathing Disorders & Treatment Product
Table 187. Dainippon Sumitomo Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 188. Dainippon Sumitomo Recent Development
Table 189. Dr. Reddy's Laboratories Company Details
Table 190. Dr. Reddy's Laboratories Business Overview
Table 191. Dr. Reddy's Laboratories Breathing Disorders & Treatment Product
Table 192. Dr. Reddy's Laboratories Revenue in Breathing Disorders & Treatment Business (2016-2021) & (US$ Million)
Table 193. Dr. Reddy's Laboratories Recent Development
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Breathing Disorders & Treatment Market Share by Type: 2020 VS 2027
Figure 2. Asthma Features
Figure 3. COPD Features
Figure 4. Allergic rhinitis Features
Figure 5. Pulmonary hypertension Features
Figure 6. Cystic fibrosis Features
Figure 7. Idiopathic pulmonary fibrosis Features
Figure 8. Global Breathing Disorders & Treatment Market Share by Application: 2020 VS 2027
Figure 9. Hospital Case Studies
Figure 10. Clinics Case Studies
Figure 11. Other Case Studies
Figure 12. Breathing Disorders & Treatment Report Years Considered
Figure 13. Global Breathing Disorders & Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Breathing Disorders & Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Breathing Disorders & Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Breathing Disorders & Treatment Market Share by Regions (2022-2027)
Figure 17. Global Breathing Disorders & Treatment Market Share by Players in 2020
Figure 18. Global Top Breathing Disorders & Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breathing Disorders & Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Breathing Disorders & Treatment Revenue in 2020
Figure 20. Global Breathing Disorders & Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Breathing Disorders & Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Breathing Disorders & Treatment Market Share by Type (2016-2027)
Figure 24. North America Breathing Disorders & Treatment Market Share by Application (2016-2027)
Figure 25. North America Breathing Disorders & Treatment Market Share by Country (2016-2027)
Figure 26. United States Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Breathing Disorders & Treatment Market Share by Type (2016-2027)
Figure 30. Europe Breathing Disorders & Treatment Market Share by Application (2016-2027)
Figure 31. Europe Breathing Disorders & Treatment Market Share by Country (2016-2027)
Figure 32. Germany Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Breathing Disorders & Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Breathing Disorders & Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Breathing Disorders & Treatment Market Share by Region (2016-2027)
Figure 42. China Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Breathing Disorders & Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Breathing Disorders & Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Breathing Disorders & Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Breathing Disorders & Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Breathing Disorders & Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Breathing Disorders & Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Breathing Disorders & Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. AstraZeneca Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 62. Boehringer Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 63. GSK Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 64. Merck Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 65. Roche Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 67. Abbott Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 68. Actavis Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 69. Afferent Pharmaceuticals Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 70. Abbott Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 71. Almirall Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 72. Amgen Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 73. AptarGroup Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 74. Astellas Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 75. Aurobindo Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 76. Axis-Shield Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 77. Baxter Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 78. Bayer Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 79. Biogen Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 80. Biotest Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 81. Bristol-Myers Squibb Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 82. Chiesi Farmaceutici Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 83. Cipla Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 84. Cytos Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 85. Dainippon Sumitomo Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 86. Dr. Reddy's Laboratories Revenue Growth Rate in Breathing Disorders & Treatment Business (2016-2021)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed


【掲載企業】

AstraZeneca、Boehringer、GSK、Merck、Roche、Novartis、Abbott、Actavis、Afferent Pharmaceuticals、Abbott、Almirall、Amgen、AptarGroup、Astellas、Aurobindo、Axis-Shield、Baxter、Bayer、Biogen、Biotest、Bristol-Myers Squibb、Chiesi Farmaceutici、Cipla、Cytos、Dainippon Sumitomo、Dr. Reddy's Laboratories

★調査レポート[世界の呼吸障害・治療市場規模・現状・予測2021-2027] (コード:QY21APR1001)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の呼吸障害・治療市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆